Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
59 y/o Male With Endocrine Complications: Fatigue and Weight Loss While on Nivolumab and Ipilimumab
Comments 0
Login to view comments.
Click here to Login